CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani
Cordoba, Argentina
Medical diagnostic imaging center in Córdoba
X5000AVE, Rondeau 293-299, X5000AVE Córdoba
About CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani
"Centro de Diagnóstico por Imagenes. Especialidades Médicas. Resonancia Magnetica con capacidad para sobrepeso. Médicina Laboral y Atención A.R.T"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
2
Eli Lilly and Company
2
Janssen Research & Development, LLC
2
Clinical Trials at CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani
During the past decade, CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
2018-02-16
2020-07-16
Terminated
311
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
2022-06-22
2024-08-11
Recruiting
538
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
2022-09-22
2025-10-25
Recruiting
840
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani
According to Clinical.Site data, the most researched conditions in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" are
"Depressive Disorder, Major" (2 trials), "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Anhedonia" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" in a lesser frequency.
Clinical Trials Intervention Types at CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani
Most popular intervention types in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Aticaprant" (2 trials), "Relamorelin" (2 trials), "Tirzepatide" (2 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani
The vast majority of trials in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani" are
6 trials for "All" genders.
Clinical Trials Status at CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani
Currently, there are NaN active trials in "CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".